140 related articles for article (PubMed ID: 1556229)
1. Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production?
Langton SR; Cesareo SD
J Clin Pathol; 1992 Mar; 45(3):221-4. PubMed ID: 1556229
[TBL] [Abstract][Full Text] [Related]
2. [Physiopathology of Helicobacter pylori infection].
Berstad AE; Berstad K; Berstad A
Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2790-3. PubMed ID: 9748810
[TBL] [Abstract][Full Text] [Related]
3. PH-activated phospholipase A2: an important mucosal barrier breaker in peptic ulcer disease.
Berstad AE; Berstad K; Berstad A
Scand J Gastroenterol; 2002 Jun; 37(6):738-42. PubMed ID: 12126256
[No Abstract] [Full Text] [Related]
4. Phospholipases A2 in gastric juice of Helicobacter pylori--positive and negative individuals.
Huhtinen HT; Grönroos JM; Haapamäki MM; Nevalainen TJ
Clin Chem Lab Med; 1999 Jan; 37(1):61-4. PubMed ID: 10094380
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase A2 activity in gastric juice from patients with active and H. pylori-eradicated healed duodenal ulcer.
Berstad K; Sjödahl R; Berstad A
Aliment Pharmacol Ther; 1994 Apr; 8(2):175-80. PubMed ID: 8038348
[TBL] [Abstract][Full Text] [Related]
6. Experimental Helicobacter felis infection in transgenic mice expressing human group IIA phospholipase A2.
Huhtinen HT; Grönroos JM; Uksila J; Grass DS; Nevalainen TJ; Laine VJ
Helicobacter; 2004 Oct; 9(5):408-16. PubMed ID: 15361079
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection.
Nardone G; Holicky EL; Uhl JR; Sabatino L; Staibano S; Rocco A; Colantuoni V; Manzo BA; Romano M; Budillon G; Cockerill FR; Miller LJ
Infect Immun; 2001 Sep; 69(9):5857-63. PubMed ID: 11500464
[TBL] [Abstract][Full Text] [Related]
8. Association of Helicobacter pylori cagA Gene with Gastric Cancer and Peptic Ulcer in Saudi Patients.
Saber T; Ghonaim MM; Yousef AR; Khalifa A; Al Qurashi H; Shaqhan M; Samaha M
J Microbiol Biotechnol; 2015 Jul; 25(7):1146-53. PubMed ID: 25791852
[TBL] [Abstract][Full Text] [Related]
9. Quantification of the interaction between lysolecithin and phospholipase A2.
Baker BL; Blaxall BC; Reese DA; Smith GR; Bell JD
Biochim Biophys Acta; 1994 Mar; 1211(3):289-300. PubMed ID: 8130262
[TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori in peptic ulcer and gastric cancer].
Matsukura N; Onda M; Yamashita K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
[TBL] [Abstract][Full Text] [Related]
11. [The effect of Helicobacter pylori infection and duodenogastric reflux on the histology of gastric mucosa in peptic ulcers].
Kopański Z; Cienciała A; Brandys J; Zastepa P; Micherdziński J; Witkowska B; Czajecki K
Folia Med Cracov; 1996; 37(1-2):3-14. PubMed ID: 9312525
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the cystathionine-γ-lyase (CES) and the severity of peptic ulcer disease.
Chen X; Wan YC; Guo T; Xu CX; Wang F
Afr Health Sci; 2014 Mar; 14(1):189-94. PubMed ID: 26060478
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies.
Ottlecz A; Romero JJ; Hazell SL; Graham DY; Lichtenberger LM
Dig Dis Sci; 1993 Nov; 38(11):2071-80. PubMed ID: 8223083
[TBL] [Abstract][Full Text] [Related]
14. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma.
Graham DY
Prev Med; 1994 Sep; 23(5):712-6. PubMed ID: 7845945
[TBL] [Abstract][Full Text] [Related]
15. How host regulation of Helicobacter pylori-induced gastritis protects against peptic ulcer disease and gastric cancer.
Dhar P; Ng GZ; Sutton P
Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G514-20. PubMed ID: 27469367
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer precursor lesions and Helicobacter pylori infection in patients with partial gastrectomy for peptic ulcer.
Giuliani A; Caporale A; Demoro M; Benvenuto E; Scarpini M; Spada S; Angelico F
World J Surg; 2005 Sep; 29(9):1127-30. PubMed ID: 16096865
[TBL] [Abstract][Full Text] [Related]
17. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated Th17 cell function is associated with increased peptic ulcer disease in Helicobacter pylori-infection.
Bagheri N; Razavi A; Pourgheysari B; Azadegan-Dehkordi F; Rahimian G; Pirayesh A; Shafigh M; Rafieian-Kopaei M; Fereidani R; Tahmasbi K; Shirzad H
Infect Genet Evol; 2018 Jun; 60():117-125. PubMed ID: 29481961
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil cationic protein and phospholipase A2 activity in human gastric juice. With emphasis on Helicobacter pylori status and effects of antacids.
Berstad K; Berstad A; Sjödahl R; Weberg R; Berstad A
Scand J Gastroenterol; 1992 Dec; 27(12):1011-7. PubMed ID: 1475616
[TBL] [Abstract][Full Text] [Related]
20. The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population.
Beltrán-Anaya FO; Poblete TM; Román-Román A; Reyes S; de Sampedro J; Peralta-Zaragoza O; Rodríguez MÁ; del Moral-Hernández O; Illades-Aguiar B; Fernández-Tilapa G
BMC Gastroenterol; 2014 Dec; 14():223. PubMed ID: 25539656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
